Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 694

1.

Intratympanic corticosteroids for sudden idiopathic sensorineural hearing loss.

Banerjee A, Parnes LS.

Otol Neurotol. 2005 Sep;26(5):878-81.

PMID:
16151332
2.

Intratympanic dexamethasone for sudden sensorineural hearing loss after failure of systemic therapy.

Haynes DS, O'Malley M, Cohen S, Watford K, Labadie RF.

Laryngoscope. 2007 Jan;117(1):3-15. Review.

PMID:
17202923
3.

Intratympanic steroids for treatment of sudden hearing loss after failure of intravenous therapy.

Plaza G, Herráiz C.

Otolaryngol Head Neck Surg. 2007 Jul;137(1):74-8.

PMID:
17599569
4.

Intratympanic steroid treatment in idiopathic sudden sensorineural hearing loss: a control study.

Xenellis J, Papadimitriou N, Nikolopoulos T, Maragoudakis P, Segas J, Tzagaroulakis A, Ferekidis E.

Otolaryngol Head Neck Surg. 2006 Jun;134(6):940-5.

PMID:
16730534
5.

Intratympanic dexamethasone and hyaluronic acid in patients with low-frequency and Ménière's-associated sudden sensorineural hearing loss.

Selivanova OA, Gouveris H, Victor A, Amedee RG, Mann W.

Otol Neurotol. 2005 Sep;26(5):890-5.

PMID:
16151334
6.

Intratympanic methylprednisolone as rescue therapy in sudden sensorineural hearing loss.

Raymundo IT, Bahmad F Jr, Barros Filho J, Pinheiro TG, Maia NA, Oliveira CA.

Braz J Otorhinolaryngol. 2010 Jul-Aug;76(4):499-509. English, Portuguese.

8.

Outcomes research analysis of continuous intratympanic glucocorticoid delivery in patients with acute severe to profound hearing loss: basis for planning randomized controlled trials.

Plontke S, Löwenheim H, Preyer S, Leins P, Dietz K, Koitschev A, Zimmermann R, Zenner HP.

Acta Otolaryngol. 2005 Aug;125(8):830-9.

PMID:
16158529
9.

Intratympanic steroid injections as a salvage treatment for sudden sensorineural hearing loss: a randomized, double-blind, placebo-controlled study.

Wu HP, Chou YF, Yu SH, Wang CP, Hsu CJ, Chen PR.

Otol Neurotol. 2011 Jul;32(5):774-9. doi: 10.1097/MAO.0b013e31821fbdd1.

PMID:
21646929
10.

Modified intratympanic treatment for idiopathic sudden sensorineural hearing loss.

Kara E, Cetik F, Tarkan O, Sürmelioğlu O.

Eur Arch Otorhinolaryngol. 2010 May;267(5):701-7. doi: 10.1007/s00405-009-1130-5.

PMID:
19862543
11.

Comparison of intermittent intratympanic steroid injection and near-continual transtympanic steroid perfusion as salvage treatments for sudden sensorineural hearing loss.

Chou YF, Chen PR, Kuo IJ, Yu SH, Wen YH, Wu HP.

Laryngoscope. 2013 Sep;123(9):2264-9. doi: 10.1002/lary.23909.

PMID:
23804460
12.

Intratympanic methylprednisolone in refractory sudden hearing loss: a 27-patient case series with univariate and multivariate analysis.

Dallan I, De Vito A, Fattori B, Casani AP, Panicucci E, Berrettini S, Marchetti M, Nacci A.

Otol Neurotol. 2010 Jan;31(1):25-30. doi: 10.1097/MAO.0b013e3181c34f18.

PMID:
19940792
13.

Combined intratympanic and systemic use of steroids for idiopathic sudden sensorineural hearing loss.

Arslan N, Oğuz H, Demirci M, Şafak MA, İslam A, Kaytez SK, Samim E.

Otol Neurotol. 2011 Apr;32(3):393-7. doi: 10.1097/MAO.0b013e318206fdfa.

PMID:
21221047
14.

Simultaneous versus subsequent intratympanic dexamethasone for idiopathic sudden sensorineural hearing loss.

Park MK, Lee CK, Park KH, Lee JD, Lee CG, Lee BD.

Otolaryngol Head Neck Surg. 2011 Dec;145(6):1016-21. doi: 10.1177/0194599811418169.

PMID:
21817157
15.

Hearing evaluation of intratympanic methylprednisolone perfusion for refractory sudden sensorineural hearing loss.

She W, Dai Y, Du X, Yu C, Chen F, Wang J, Qin X.

Otolaryngol Head Neck Surg. 2010 Feb;142(2):266-71. doi: 10.1016/j.otohns.2009.10.046.

PMID:
20115986
16.

Intratympanic dexamethasone/hyaluronic acid mix as an adjunct to intravenous steroid and vasoactive treatment in patients with severe idiopathic sudden sensorineural hearing loss.

Gouveris H, Schuler-Schmidt W, Mewes T, Mann W.

Otol Neurotol. 2011 Jul;32(5):756-60. doi: 10.1097/MAO.0b013e31821a3fc3.

PMID:
21646933
17.

Intratympanic steroid injection for treatment of idiopathic sudden hearing loss.

Slattery WH, Fisher LM, Iqbal Z, Friedman RA, Liu N.

Otolaryngol Head Neck Surg. 2005 Aug;133(2):251-9.

PMID:
16087024
18.

Randomized, double blind, placebo controlled trial on the safety and efficacy of continuous intratympanic dexamethasone delivered via a round window catheter for severe to profound sudden idiopathic sensorineural hearing loss after failure of systemic therapy.

Plontke SK, Löwenheim H, Mertens J, Engel C, Meisner C, Weidner A, Zimmermann R, Preyer S, Koitschev A, Zenner HP.

Laryngoscope. 2009 Feb;119(2):359-69. doi: 10.1002/lary.20074.

PMID:
19172627
19.
20.

Comparison of intratympanic and intravenous dexamethasone treatment on sudden sensorineural hearing loss with diabetes.

Kakehata S, Sasaki A, Oji K, Futai K, Ota S, Makinae K, Shinkawa H.

Otol Neurotol. 2006 Aug;27(5):604-8.

PMID:
16788418
Items per page

Supplemental Content

Support Center